dc.contributor.author | Kitchen, P | |
dc.contributor.author | Lee, KY | |
dc.contributor.author | Clark, D | |
dc.contributor.author | Lau, N | |
dc.contributor.author | Lertsuwan, J | |
dc.contributor.author | Sawasdichai, A | |
dc.contributor.author | Satayavivad, J | |
dc.contributor.author | Oltean, S | |
dc.contributor.author | Afford, S | |
dc.contributor.author | Gaston, K | |
dc.contributor.author | Jayaraman, P-S | |
dc.date.accessioned | 2020-01-02T11:21:46Z | |
dc.date.issued | 2019-12-16 | |
dc.description.abstract | Aberrant Notch and Wnt signalling are known drivers of cholangiocarcinoma (CCA) but the underlying factors that initiate and maintain these pathways are not known. Here we show that the PRH/HHEX transcription factor forms a positive transcriptional feedback loop with Notch3 that is critical in CCA. PRH/HHEX expression was elevated in CCA and depletion of PRH reduced CCA tumour growth in a xenograft model. Overexpression of PRH in primary human biliary epithelial cells was sufficient to increase cell proliferation and produce an invasive phenotype. Interrogation of the gene networks regulated by PRH and Notch3 revealed that unlike Notch3, PRH directly activated canonical Wnt signalling. These data indicate that hyperactivation of Notch and Wnt signalling is independent of the underlying mutational landscape and has a common origin in dysregulation of PRH. Moreover, they suggest new therapeutic options based on the dependence of specific Wnt, Notch, and CDK4/6 inhibitors on PRH activity. | en_GB |
dc.description.sponsorship | Medical Research Council (MRC) | en_GB |
dc.description.sponsorship | Thailand Research Fund (TRF) | en_GB |
dc.identifier.citation | Published online 16 December 2019 | en_GB |
dc.identifier.doi | 10.1158/0008-5472.CAN-19-0942 | |
dc.identifier.grantnumber | MR/N012615/1 | en_GB |
dc.identifier.grantnumber | DBG5980005 | en_GB |
dc.identifier.other | 0008-5472.CAN-19-0942 | |
dc.identifier.uri | http://hdl.handle.net/10871/40208 | |
dc.language.iso | en | en_GB |
dc.publisher | American Association for Cancer Research | en_GB |
dc.relation.url | https://www.ncbi.nlm.nih.gov/pubmed/31843982 | en_GB |
dc.rights.embargoreason | Under embargo until 16 December 2020 in compliance with publisher policy | en_GB |
dc.rights | © 2019, American Association for Cancer Research | en_GB |
dc.subject | cholangiocarcinoma | en_GB |
dc.subject | bile duct | en_GB |
dc.subject | biliary epithelial cells | en_GB |
dc.subject | cholangiocyte | en_GB |
dc.subject | HHEX | en_GB |
dc.subject | PRH | en_GB |
dc.subject | Notch | en_GB |
dc.subject | Wnt | en_GB |
dc.subject | epithelial-mesenchymal transition | en_GB |
dc.title | A runaway PRH/HHEX-Notch3 positive feedback loop drives cholangiocarcinoma and determines response to CDK4/6 inhibition | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2020-01-02T11:21:46Z | |
exeter.place-of-publication | United States | en_GB |
dc.description | This is the author accepted manuscript. The final version is available from the American Association for Cancer Research via the DOI in this record | en_GB |
dc.identifier.journal | Cancer Research | en_GB |
dc.rights.uri | http://www.rioxx.net/licenses/all-rights-reserved | en_GB |
dcterms.dateAccepted | 2019-12-10 | |
rioxxterms.version | AM | en_GB |
rioxxterms.licenseref.startdate | 2019-12-16 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2020-01-02T11:19:23Z | |
refterms.versionFCD | AM | |
refterms.dateFOA | 2020-01-02T11:21:55Z | |
refterms.panel | A | en_GB |